Robin Visvanathar is the Co-Founder of IONLACE, where he leverages his dual MD/PhD from Uppsala University to build AI that assembles new molecules. A recognized leader in his field, he was named to the Forbes 30 Under 30 list for Science and Healthcare in 2024 and selected as an H. R. H. Prince Daniel Fellow.
Beyond his primary role, Robin is an active angel investor and advisor. He focuses on supporting promising startups and innovators working at the intersection of artificial intelligence and health or biotechnology, reflecting a deep personal commitment to advancing the field from multiple angles.
He is an H. R. H. Prince Daniel Fellow, an honor awarded by the Royal Swedish Academy of Engineering Sciences to support promising entrepreneurs.
Robin Visvanathar
Co-Founder at IONLACE
Stockholm, Stockholm County, Sweden
Overview
Topics They Care About
AI in Drug Discovery
His current company, IONLACE, and his past role at Enveda are focused on using AI to change how medicines are made and discovered.
Synthetic Biology
His company, IONLACE, is described as working at the frontier of AI and synthetic biology to create new molecules for diagnostics and medicine.
Bio-Tech Investing
Has direct experience as a venture capital Investment Analyst at Hadean Ventures and currently acts as an angel investor in the health and biology sectors.
Media Appearances
Robin has no verified media appearances
Work History
6-2023
Co-Founder at IONLACE
Education
Doctor of Medicine - MD from Uppsala University
Doctor of Philosophy - PhD from Uppsala University
More Information
Social Presence :
Prographics :
Exp : 2
Location : Stockholm, Stockholm County, Sweden
Job Level : Leadership
Designation : Co-Founder at IONLACE
